| Literature DB >> 34822603 |
Abstract
The contamination of food and feeds with mycotoxins poses a global health risk to humans and animals, with major economic consequences. Good agricultural and manufacturing practices can help control mycotoxin contamination. Since these actions are not always effective, several methods of decontamination have also been developed, including physical, chemical, and biological methods. Biological decontamination using microorganisms has revealed new opportunities. However, these biological methods require legal regulations and more research before they can be used in food production. Currently, only selected biological methods are acceptable for the decontamination of feed. This review discusses the literature on the use of microorganisms to remove mycotoxins and presents their possible mechanisms of action. Special attention is given to Saccharomyces cerevisiae yeast and lactic acid bacteria, and the use of yeast cell wall derivatives.Entities:
Keywords: adsorption; decontamination; detoxification; lactic acid bacteria; microorganisms; mycotoxins; yeasts
Mesh:
Substances:
Year: 2021 PMID: 34822603 PMCID: PMC8619243 DOI: 10.3390/toxins13110819
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1RASFF notifications of excessive levels of mycotoxins from 2015 to 2021. Detailed data on the type of notification, mycotoxins, and products category relate to 2021.
Figure 2Mycotoxin control strategies.
Figure 3Number of publications on mycotoxin biodegradation from 1990 to 2021, based on the results of searching the Web of Science Core Collection (total = 8854).
Reports concerning the microbial decontamination of mycotoxins in the years 2011–2021.
| Microorganisms | Targeted Mycotoxins | Mechanism | References |
|---|---|---|---|
| Bacteria | |||
|
| OTA | Biodegradation to OTα | [ |
|
| OTA | Biodegradation to OTα due to carboxypeptidase activity | [ |
|
| ZEN | Adsorption to bacterial cells | [ |
|
| ZEN | Adsorption to bacterial cells | [ |
|
| OTA | Adsorption to bacterial cells | [ |
|
| ZEN | Biotransformation due to esterase activity | [ |
|
| AFB1 | Biotransformation into less toxic products due to laccase activity | [ |
|
| DON | NA | [ |
|
| OTA | Adsorption to bacterial cells | [ |
|
| ZEN; 17-β-estradiol | Biotransformation into ZEN-14-phosphate and 17-β-estradiol-3-phosphate | [ |
|
| AFB1 | Biotransformation into less cytotoxic products | [ |
|
| OTA | Biodegradation to OTα | [ |
|
| OTA, AFB1, ZEN, T-2 | Biotransformation into undefined products with lower toxicity | [ |
|
| DON | Biotransformation into 3-keto-DON | [ |
|
| AFB1 | Biotransformation into less toxic products (C16H14O5 and other metabolites) | [ |
| PAT | Enzymatic biotransformation into E-ascladiol | [ | |
|
| AFB1, OTA, CIT, PAT | Physical binding to bacterial cell wall proteins and polysaccharides | [ |
| OTA | Adsorption into the bacterial cell wall | [ | |
|
| PAT | Biotransformation into E-ascladiol | [ |
|
| PAT | Simultaneous partial biotransformation into an undefined product and adsorption into the bacterial cell wall | [ |
|
| ZEN | NA | [ |
|
| ZEN | Biotransformation due to esterase activity | [ |
| ZEN | Enzymatic biotransformation | [ | |
| OTA | Biodegradation to OTα | [ | |
|
| DON | Biotransformation into 3-keto-DON and 3-epi-DON as intermediate products | [ |
|
| OTA | Biodegradation to OTα | [ |
|
| DON | Biotransformation into less-toxic 3-keto-DON by oxidation of the C3 hydroxyl group | [ |
|
| AFB1 | Non-enzymatic transformation into C17H14O7 | [ |
|
| AFB1 | NA | [ |
|
| ZEN | Biotransformation into non-estrogenic undefined products | [ |
|
| AFB1, T-2 | Biotransformation into undefined non genotoxic products | [ |
| FB1 | Biodegradation into an undefined hydrolyzed product due to carboxyesterase activity | [ | |
| AFB1 | Biotransformation into undefined less genotoxic products | [ | |
| Bacterial consortium isolated from soil ( | DON | Biotransformation into 3-keto-DON | [ |
| Microorganisms from Kefir grains ( | AFB1, ZEN, OTA | Adsorption | [ |
| Bacterial consortium consists of | AFB1, ZEN, | NA | [ |
| Bacterial consortium isolated from spent mushroom compost: | FB1 | Enzymatic transformation into low-toxicity metabolites | [ |
| Yeasts | |||
|
| PAT | Biotransformation into E-ascladiol with short-chain dehydrogenase/reductase | [ |
|
| ZEN | Biotransformation into less toxic β-zearalenol (β-ZOL) and zearalenone-14,16-diglucosid | [ |
|
| ZEN, OTA, AFB1 | Adsorption into cell wall preparation | [ |
|
| PAT | Biotransformation into E- and Z-ascladiol | [ |
|
| FB1 | Biotransformation due to fumonisin esterase | [ |
|
| PAT | Biotransformation into undefined products | [ |
|
| PAT | Biodegradation | [ |
|
| OTA | Biotransformation into undefined productsOTα and sodium adduct of OTα with loss of the coumarin group | [ |
|
| PAT | Enzymatic biodegradation | [ |
|
| PAT | Biotransformation into desoxypatulinic acid | [ |
|
| PAT | Enzymatic biotransformation by orotate phosphoribosyltransferase | [ |
|
| PAT | Adsorption to proteins and polysaccharides in the cell walls | [ |
|
| OTA | Adsorption by cell wall polysaccharides | [ |
|
| OTA | Adsorption | [ |
|
| DON, HT-2, T-2 | Biodegradation and/or adsorption | [ |
|
| DON, ZEN | Adsorption by yeast cells | [ |
| AOH, AME | Adsorption | [ | |
|
| OTA | Biodegradation into less toxic products | [ |
| Microorganisms isolated from Kombucha culture: | AFB1 | Biodegradation into less toxic products | [ |
| Molds | |||
|
| OTA | Biodegradation into ochratoxin α by extracellular ochratoxinase | [ |
|
| AFB1 | Biodegradation into AFB2-GOH | [ |
|
| PAT | Biodegradation | [ |
|
| ZEA | Biotransformation into a less toxic product due to lactonase activity followed by decarboxylation | [ |
|
| AFs | Biodegradation | [ |
|
| AFB1 | Biotransformation into less cytotoxic products | [ |
1 formerly belonging to Lactobacillus genera. AFB1—aflatoxin B1; OTA—ochratoxin A; PAT—patulin; ZEN—zearalenone; DON—deoxynivalenol; CIT—citrinin; FB1—fumonisin B1; AOH—alternariol; AME—alternariol monomethyl ether; AFB2-GOH—AFB2 coupling with glutathione; 2 yeasts strain; NA—detailed data unavailable.
Figure 4Criteria for acceptability of microbiological decontamination methods.
Figure 5Advantages and limitations of biological methods of decontamination.